Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III trial of Cui-Tang granules for influenza
ChiCTR1900020945Phase 3Recruiting
- Sponsor
- Beijing Hospital of Traditional Chinese Medicine
- Start
- Jan 2018
- Countries
- 1
01
Overview
Phase 3 trial of Cui-Tang granules in influenza (2 arms), sponsored by Beijing Hospital of Traditional Chinese Medicine. Primary endpoint: 3-day antipyretic rate. Started Jan 2018; status: recruiting.
02
Drugs
Cui-Tang granules
03
Conditions
influenza
Beyond the preview
Go deeper on ChiCTR1900020945.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1900020945.